clofibrate has been researched along with metformin in 20 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 10 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (5.00) | 29.6817 |
2010's | 9 (45.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Glen, RC; Lowe, R; Mitchell, JB | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Verstraete, M | 1 |
Alberti, KG; Betteridge, DJ; Cudworth, AG; De Silva, SR; Shawe, JE | 1 |
Chakrabarti, R; Fearnley, GR | 1 |
Baggio, G; Baiocchi, MR; Briani, G; Crepaldi, G; Fellin, R | 1 |
Bardfeld, PA; Bodian, JE; Hellman, L; Sachs, BA; Sugarman, LA | 1 |
Gormsen, J; Laursen, B | 2 |
Gormsen, J | 1 |
Clarke, BF; Duncan, LJ | 1 |
Fearnley, GR | 1 |
Asai, M; Hashimoto, K; Iwasaki, Y; Kambayashi, M; Nishiyama, M; Taguchi, T; Takayasu, S; Tsugita, M; Yoshida, M | 1 |
3 review(s) available for clofibrate and metformin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
The position of long-term stimulation of the endogenous fibrinolytic system: present achievements and clinical perspectives.
Topics: Adrenocorticotropic Hormone; Anabolic Agents; Androgens; Clofibrate; Coronary Disease; Deamino Arginine Vasopressin; Drug Therapy, Combination; Female; Fibrinolysis; Fibrinolytic Agents; Glucocorticoids; Humans; Inflammation; Male; Metformin; Phenformin; Plasminogen Activators; Postoperative Complications; Sulfonylurea Compounds; Thromboembolism; Thrombophlebitis; Vascular Diseases | 1975 |
Advances in the treatment of diabetes mellitus.
Topics: Blood Glucose; Chlorpropamide; Clofibrate; Diabetes Mellitus; Diabetic Coma; Diabetic Ketoacidosis; Diabetic Retinopathy; Diet Therapy; Humans; Hypoglycemia; Insulin; Kidney Transplantation; Lactates; Light Coagulation; Metformin; Methods; Pancreas Transplantation; Phenformin; Pituitary Gland; Renal Dialysis; Sulfonylurea Compounds; Tolbutamide | 1971 |
2 trial(s) available for clofibrate and metformin
Article | Year |
---|---|
Metformin and clofibrate in maturity onset diabetes mellitus: advantages of combined treatment.
Topics: Alanine; Blood Glucose; Cholesterol; Circadian Rhythm; Clofibrate; Diabetes Mellitus; Drug Synergism; Fibrinogen; Glycerol; Humans; Hydroxybutyrates; Lactates; Lipoproteins; Metformin; Triglycerides | 1979 |
Liver scan in hyperlipoproteinemia.
Topics: Adult; Aged; Aspartate Aminotransferases; Blood Protein Disorders; Blood Protein Electrophoresis; Cholesterol; Clinical Trials as Topic; Clofibrate; Colloids; Ethers, Cyclic; Female; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipoproteins; Liver; Liver Diseases; Male; Metformin; Middle Aged; Oxandrolone; Phenotype; Placebos; Polyamines; Polymers; Radionuclide Imaging; Sulfur; Technetium; Triglycerides | 1974 |
15 other study(ies) available for clofibrate and metformin
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Pharmacological fibrinolysis.
Topics: Administration, Oral; Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Clofibrate; Delayed-Action Preparations; Drug Resistance; Drug Therapy, Combination; Ethylestrenol; Female; Fibrin; Fibrinolysis; Humans; Male; Metformin; Methadone; Nandrolone; Phenformin; Stimulation, Chemical; Sulfonylurea Compounds; Testosterone; Time Factors | 1972 |
[Treatment of hyperlipoproteinemias (author's transl)].
Topics: Adolescent; Adult; Anticholesteremic Agents; Child; Cholestyramine Resin; Clofibrate; Dextrothyroxine; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Ion Exchange Resins; Lipoproteins; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Metformin; Middle Aged; Nicotinic Acids; Phenformin | 1974 |
Studies on pharmacological enhancement of blood fibrinolytic activity.
Topics: Aged; Arteriosclerosis; Clofibrate; Female; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Humans; Immunodiffusion; Male; Metformin; Middle Aged; Plasminogen; Serum Globulins; Stimulation, Chemical; Testosterone; Thrombosis; Tolazamide | 1970 |
Fibrinolytic activity and haemagglutination inhibition immunoassays.
Topics: Adult; Aged; Biguanides; Clofibrate; Coronary Disease; Ethylestrenol; Female; Fibrin; Fibrinogen; Fibrinolysis; Hemagglutination Inhibition Tests; Hemostasis; Humans; Immunoassay; Immunodiffusion; Immunoelectrophoresis; Liver Cirrhosis; Male; Metformin; Middle Aged; Neoplasm Metastasis; Nicotinic Acids; Physical Exertion; Plasminogen; Prostatic Neoplasms; Stimulation, Chemical; Time Factors; Tolazamide | 1970 |
[Physiological and pharmacological aspects of fibrinolysis].
Topics: Adrenal Cortex Hormones; Anabolic Agents; Arteriosclerosis Obliterans; Biguanides; Blood Coagulation Tests; Blood Platelets; Clofibrate; Coronary Disease; Diabetes Mellitus; Ethylestrenol; Fibrinolysis; Humans; Insulin; Metformin; Myocardial Infarction; Phenformin; Sulfonylurea Compounds; Testosterone; Thrombosis | 1971 |
Pharmacological enhancement and short-term stimulation of blood fibrinolytic activity.
Topics: Adolescent; Adult; Aged; Aminocaproates; Anticholesteremic Agents; Arteriosclerosis; Arthritis, Rheumatoid; Asthma; Clofibrate; Diabetes Mellitus; Female; Fibrinogen; Fibrinolysis; Humans; Hypoglycemic Agents; Immunoassay; Intermittent Claudication; Kidney Failure, Chronic; Liver Cirrhosis; Lung Neoplasms; Male; Metformin; Middle Aged; Neoplasm Metastasis; Nicotinic Acids; Phlebitis; Physical Exertion; Plasminogen; Primary Myelofibrosis; Propionates; Pulmonary Heart Disease; Testosterone; Tolazamide; Urea | 1969 |
Is the metabolic syndrome an intracellular Cushing state? Effects of multiple humoral factors on the transcriptional activity of the hepatic glucocorticoid-activating enzyme (11beta-hydroxysteroid dehydrogenase type 1) gene.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Animals; Anticholesteremic Agents; Base Sequence; Cell Line; Chromans; Clofibrate; Cortisone; Cushing Syndrome; Dexamethasone; Gene Expression Regulation, Enzymologic; Glucocorticoids; Humans; Hydrocortisone; Hypoglycemic Agents; Insulin; Interleukin-1beta; Liver; Metabolic Syndrome; Metformin; Molecular Sequence Data; Receptors, Glucocorticoid; Thiazolidinediones; Transcription Factor AP-1; Troglitazone; Tumor Necrosis Factor-alpha | 2008 |